Home
/
Glossary
/
Data Migration Risk Assessment
General Biopharmaceutical Concepts

Data Migration Risk Assessment

Data migration risk assessment identifies and evaluates risks associated with transferring regulated data between systems while maintaining integrity and traceability.

Data migration risk assessment evaluates vulnerability and safety concerns when transferring pharmaceutical data between systems. Legacy system decommissioning transfers records to modern archival systems. Database conversions require validation confirming data integrity throughout transfer. Encryption implementation protects sensitive information during transit. Audit trail maintenance ensures accountability and retrieval capability.

Backup systems and disaster recovery testing protect against data loss. Parallel system operation during transitions enables cross-validation. Regulatory requirements mandate comprehensive data governance during migrations. Quality management systems incorporate migration risk assessment planning. Post-migration validation confirms equivalent data accessibility and completeness.

📘 Explore the Glossary

✓ 903 Definitions

✓ 18 Categories

✓ Updated Weekly

Continue Exploring

Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.

Browse Glossary →
WhatsApp